Product Details
1/EA
$ *.**
Limited QuantitiesAdditional Information
| Product Name | Spravato 56 mg Dose Kit 2x28 mL 3N |
| Application | Treatment-resistant depression |
| Generic Drug Name | Esketamine |
| Mechanism of Action | Esketamine acts as an NMDA receptor antagonist, modulating glutamate neurotransmission to promote synaptic plasticity and rapid antidepressant effects |
| Strength | 56 mg per spray dose |
| Volume | 2 x 28 mL |
| Onset of Action | Rapid onset within hours, with peak effects typically occurring within hours after administration |
| Duration of Action | Effects may last several hours, requiring regular treatments (weekly or bi-weekly) for sustained benefits |
| Side Effects | Dizziness, dissociation, elevated blood pressure, nausea, headache, and sedation |
| Latex Free Indicator | Latex-free |
| Packaging | Supplied as a kit containing 2 vials of 28 mL each |
| Uses | Indicated for treatment-resistant depression in adults, as part of a treatment regimen that includes oral antidepressants |
Description
Spravato 56 mg Dose Kit 2x28 mL 3N is a nasal spray formulation of esketamine, indicated for treatment-resistant depression in adults. Esketamine, a rapidly acting N-methyl-D-aspartate (NMDA) receptor antagonist, provides fast-acting relief for patients who have not responded adequately to traditional antidepressant treatments. By modulating glutamate, a key neurotransmitter in the brain, esketamine is believed to restore synaptic connections and enhance neural plasticity.
Each kit contains two 28 mL bottles of esketamine solution, with each spray delivering 56 mg of esketamine per dose. The nasal spray is administered under medical supervision in a certified healthcare facility due to the potential for side effects and the need for monitoring.
Spravato is indicated for patients who have failed at least two different antidepressant treatments for major depressive disorder. It is often prescribed as part of a comprehensive treatment plan that includes oral antidepressants. Common side effects of Spravato include dizziness, dissociation, and increased blood pressure.
Frequently Asked Questions (FAQs)
The cost of SPRAVATO 56MG DOSE KT 2X28G 3N is $$0.00
SPRAVATO 56MG DOSE KT 2X28G 3N is manufactured by Janssen.
You can purchase SPRAVATO 56MG DOSE KT 2X28G 3N on our website at https://supplies.pipelinemedical.com/product/detail/spravato-56mg-dose-kt-2x28g-3n-417956